Novartis | NVS - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 508.97B 46.71B 2026-11
Amgen USD 247.94B 20.06B 2026-11
AstraZeneca USD 213.88B 23.43B 2026-11
Bausch Health Companies USD 4.13B 1.95B 2026-11
Biogen USD 33.38B 1.48B 2026-09
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Canopy Growth CAD 88.38M 494.19M 2026-11
Corcept Therapeutics USD 8.58B 3.87B 2026-11
Drreddys Laboratories INR 2.29B 8.43B 2026-11
Eli Lilly USD 1.09T 40.33B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Glaxosmithkline GBP 101.7B 4.58B 2026-11
J&J USD 653.61B 42.25B 2026-09
Merck USD 375.59B 17.09B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Novartis USD 328.21B 54.92B 2026-11
Pacira USD 1.69B 695M 2026-11
Perrigo USD 2.17B 31M 2026-11
Pfizer USD 169.88B 6.47B 2026-11
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.2B 38M 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 100.56B 13.53B 2026-11
Sanofi EUR 114.34B 15.65B 2026-11
Supernus Pharmaceuticals USD 2.51B 193M 2026-09
Zoetis USD 37.6B 8.74B 2026-11